Steven M Fruchtman is PRESIDENT, CHIEF EXECUTIVE OFF of Onconova Therapeutics, Inc.. Currently has a direct ownership of 74,792 shares of ONTX, which is worth approximately $44,127. The most recent transaction as insider was on Mar 14, 2024, when has been sold 8,727 shares (Common Stock) at a price of $0.9 per share, resulting in proceeds of $7,854. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 74.8K
0% 3M change
54.85% 12M change
Total Value Held $44,127

Steven M Fruchtman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 14 2024
SELL
Payment of exercise price or tax liability
$7,854 $0.9 p/Share
8,727 Reduced 10.45%
74,792 Common Stock
Mar 13 2024
BUY
Exercise of conversion of derivative security
-
23,111 Added 21.67%
83,519 Common Stock
Feb 07 2024
SELL
Payment of exercise price or tax liability
$6,172 $0.67 p/Share
9,212 Reduced 13.23%
60,408 Common Stock
Feb 07 2024
BUY
Exercise of conversion of derivative security
-
21,320 Added 23.44%
69,620 Common Stock
Aug 03 2023
SELL
Payment of exercise price or tax liability
$4,791 $1.01 p/Share
4,744 Reduced 8.94%
48,300 Common Stock
Aug 02 2023
BUY
Exercise of conversion of derivative security
-
12,567 Added 19.15%
53,044 Common Stock
Feb 07 2023
SELL
Payment of exercise price or tax liability
$9,488 $1.36 p/Share
6,977 Reduced 14.7%
40,477 Common Stock
Feb 07 2023
BUY
Exercise of conversion of derivative security
-
21,320 Added 31.0%
47,454 Common Stock
Aug 03 2022
SELL
Payment of exercise price or tax liability
$6,022 $1.32 p/Share
4,562 Reduced 14.86%
26,134 Common Stock
Aug 02 2022
BUY
Exercise of conversion of derivative security
-
12,566 Added 29.05%
30,696 Common Stock
Sep 28 2021
BUY
Open market or private purchase
$10,000 $4.2 p/Share
2,381 Added 11.61%
18,130 Common Stock
Feb 16 2021
BUY
Open market or private purchase
$20,000 $1.0 p/Share
20,000 Added 7.81%
236,226 Common Stock
Nov 25 2020
BUY
Open market or private purchase
$10,400 $0.26 p/Share
40,000 Added 15.61%
216,226 Common Stock
SMF

Steven M Fruchtman

PRESIDENT, CHIEF EXECUTIVE OFF
Newtown, PA

Track Institutional and Insider Activities on ONTX

Follow Onconova Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ONTX shares.

Notify only if

Insider Trading

Get notified when an Onconova Therapeutics, Inc. insider buys or sells ONTX shares.

Notify only if

News

Receive news related to Onconova Therapeutics, Inc.

Track Activities on ONTX